BRIEF-Lundbeck, Takeda receive CRL from FDA for Trintellix (vortioxetine) sNDA
* Lundbeck and Takeda receive complete response letter from the FDA for Trintellix® (vortioxetine) sNDA
April 11Human Stem Cells Institute (HSCI) :
* Said on Monday that it has increased its stake in Center of Genetics and Reproductive Medicine GENETICO (Genetico) to 79.99 percent from 73.08 percent
Source text - bit.ly/2nzt85S
Further company coverage: (Gdynia Newsroom)
June 22 A U.S. judge accepted on Thursday major revisions to Arizona's death penalty procedures, such as eliminating paralytic drugs in lethal injections and giving witnesses more access to watch prisoners inside the death chamber, a lawyer for the death row inmates said.
(Adds details on mutual funds and ETFs, analyst quote, table, byline) By Trevor Hunnicutt NEW YORK, June 22 Investors pulled back from U.S.-based stock funds after pouring the most cash into those investments since February the previous week, Lipper data showed on Thursday. Withdrawals of $2.2 billion struck U.S.-based equity mutual funds and exchange-traded funds during the week ended June 21, the research service said, during a rollercoaster week for stocks and as the